期刊文献+

RICU病房患者病原菌分布及鲍氏不动杆菌耐药监测

Distribution of pathogens bacteria and drug resisitance of acinetobacter Baumannii in respiratory intensive care unit
下载PDF
导出
摘要 目的分析呼吸重症监护病房(RICU)感染的病原菌种类及鲍氏不动杆菌耐药情况。方法使用BD Phoenix100全自动细菌分析仪进行病原菌种类鉴定和耐药检测,运用Whonet 5.6进行分析。结果 RICU常见病原菌以革兰阴性杆菌为主,其中鲍氏不动杆菌居首位,且鲍氏不动杆菌的物耐药率分别为亚胺培南48.2%、美洛培南45.8%、头孢噻肟100%、头孢他啶65.0%、头孢吡肟41.4%、庆大霉素60.4%、阿米卡星44.5%,左氧氟沙星29.6%。结论呼吸重症监护病房RICU的病原菌中,以革兰阴性杆菌居多,其中鲍氏不动杆菌居于首位,且药敏结果显示多重耐药,应加强对(RICU)患者的多重耐药菌监测。 Objective To investigate the distribution of pathogens bacteria and drug resistance of acinetobacter baumannii in respiratory intensive care unit (RICU). Methods BD Phoenix 100 full -automiatic system was used for bacteria identification and drug resisitance monitoring and Whonet 5.6 was employed for data analysis. Results Gram - negative bacteria was the major variety in RICU. As for drug resistance rate of aeinetohaeter baumannii, imipenem was 48.2% , meropenem was 45.8% , cefotaixime was 100% , ceftazidime was 65.0% , cefepime was 41.4% , gentamicin was 60.4% , amikacin was 44.5% , and levofloxacin was 29. 6%. Conclusion Gram - negative bacteria is the most common variety of pathogens in the respiratory intensive care unit (RICU) , among which acinetobacter baumannii dominates, and show multi - drug resistance. Theretbre, patient monitoring should be strengthened.
出处 《河南医学研究》 CAS 2017年第21期3854-3856,共3页 Henan Medical Research
关键词 呼吸重症监护病房 鲍氏不动杆菌 耐药 RICU acinetobacter baumannii drug resistence
  • 相关文献

参考文献8

二级参考文献65

  • 1王刚,黄洁,秦帅,汤耀卿.不同抗菌药物对ICU泛耐药鲍曼不动杆菌感染的疗效比较[J].上海交通大学学报(医学版),2011,31(1):111-114. 被引量:22
  • 2Rishi D,John C. Infection in the intensive care unit(ICU)[J]. Current Anaesthesia & Critical Care, 2009,20 : 175-182.
  • 3Agarwal R, Gupta D, Ray P, et al. Epidemiology, risk factor and outcome of nosocomial infections in a respiratory intensive care unit in north India[J]. J Infect,2006,53(2):98-105.
  • 4Vincent JL. Nosocomial infections in adult intensive-care units [J]. Lancet,2003,361(9374) :2068-2077.
  • 5Satlin MJ, Calfee DP, Chen L, et al. Emergence of carbapenemresistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies [J]. Leuk Lymphoma, 2013,54(4) :799-806.
  • 6Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae , importance of combination therapy[J]. Clin Infect Dis,2012 ,55 (7) :943-950.
  • 7Queenan AM, Bush K. Carbapenemases , the versatile beta- lactamases[J]. Clin Microbiol Rev ,2007,20(3) :440458.
  • 8Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement, MI00-S24 [S J . Wayne, PA: Clinical and Laboratory Standards Institute ,2014.
  • 9Gupta N, Limbago BM, Patel IB, et al. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention [J]. Clin Infect Dis, 2011 ,53 (1) :60-67.
  • 10Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae oarhapenemasesj L]. Lancet Infect Dis,2013 ,13(9) :785-796.

共引文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部